NL-OMON52550招募中2 期
Immune profiling of stage III non-small cell lung cancer patients treated with concurrent chemoradiation and adjuvant durvalumab: A prospective observational phase II trial - Immune profiling of stage III NSCLC patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Pathological diagnosis of adequately staged (according to standard practice
- •using chest-CT, FDG-PET, brain imaging MRI/CT) NSCLC
- •Participant is willing and able to give informed consent for participation in
- •Male or female, aged 18 years or above
- •Scheduled to receive one of the following two therapeutic strategies:
- •o Concurrent chemotherapy and radiotherapy with photons (60 Gy in 30 fractions
- •of 2 Gy) in patients with stage III NSCLC
- •o Concurrent chemotherapy and radiotherapy with protons (60 Gy in 30 fractions
- •of 2 Gy) in patients with stage III NSCLC
- •Is able and willing to comply with all trial requirement
排除标准
- •Mixed non-small cell lung cancer with other histologies such as small cell
- •lung cancer
- •Not able to comply with the study protocol
- •Less than 18 years* old
- •Pregnancy or not able to comply with adequate contraception in women with
- •child baring potential
- •Previous radiotherapy to the chest for benign or malignant conditions,
- •including radiation for breast cancer
- •Previous malignancy treated with chemotherapy, immune therapy or radiotherapy
- •(irrespective of when this happened)
- •Previous malignancies treated with surgery only are allowed if 2 years or
- •more before inclusion in the present study
研究者
相似试验
已完成
不适用
Analysis of immune status in non-small cell lung cancer patients with EGFR mutationsnon-small cell lung cancerJPRN-UMIN000031076ational Cancer Center30
进行中（未招募）
不适用
Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II TrialCarcinoma, Non-Small-Cell LungNCT04432142Maastricht Radiation Oncology45
已完成
不适用
tritional Assessment in Non-small Cell lung cancer patientslungcancerNon Small Cell Lung Cancer10038666NL-OMON50451Antoni van Leeuwenhoek Ziekenhuis100
已完成
不适用
Early response measurement in non small cell lung cancer.1003866610029107non-small cell lung cancerlung cancerNL-OMON31456niversitair Medisch Centrum Sint Radboud50
已完成
3 期
A study to evaluate immune non-inferiority and safety of Tetravalent Rotavirus Vaccine (BRV-TV) in comparison to licensed vaccine (RotaTeq) in healthy infants.CTRI/2014/08/004893Shantha Biotechnics Limited1,182